BMY Shares Outstanding History
Below is a table of the BMY shares outstanding history going back to 2/1/2010:

Date BMY Shares Outstanding
2/1/20101.71B
3/31/20101.72B
6/30/20101.71B
9/30/20101.71B
2/1/20111.70B
3/31/20111.71B
6/30/20111.71B
9/30/20111.69B
2/1/20121.69B
3/31/20121.69B
6/30/20121.68B
9/30/20121.65B
2/1/20131.64B
3/31/20131.64B
6/30/20131.65B
9/30/20131.65B
2/1/20141.65B
3/31/20141.66B
6/30/20141.66B
9/30/20141.66B
2/2/20151.66B
3/31/20151.67B
6/30/20151.67B
9/30/20151.67B
2/1/20161.67B
3/31/20161.67B
6/30/20161.67B
9/30/20161.67B
2/1/20171.67B
3/31/20171.65B
6/30/20171.64B
9/30/20171.64B
2/1/20181.63B
3/31/20181.63B
6/30/20181.63B
9/30/20181.63B
2/1/20191.63B
3/31/20191.64B

Also see: BMY Market Cap History
and BMY YTD Return
BMY Historical Shares Outstanding:
-0.51% CAGR
BMY Historical Shares Outstanding: +-0.51% CAGR

Mouse over chart for data details
2/1/2010 ...3/31/2019
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Co.'s products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. Co. manufactures products in the U.S., Puerto Rico and in four foreign countries. Co. has products in the following therapeutic classes: oncology; cardiovascular; and immunoscience. Co.'s products include: Opdivo; Eliquis; Orencia; Sprycel; Yervoy; Empliciti; Baraclude; the Reyataz Franchise; the Sustiva Franchise; and the Hepatitis C Franchise. We show 38 historical shares outstanding datapoints in our coverage of BMY's shares outstanding history.

Understanding the changing numbers of BMY shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BMY versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BMY by allowing them to research BMY shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for BMY:
BMY SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bristol-Myers Squibb (BMY) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

BOLD Shares Outstanding History
BPMC Shares Outstanding History
BPTH Shares Outstanding History
BRKR Shares Outstanding History
BSPM Shares Outstanding History
BSTC Shares Outstanding History
BSX Shares Outstanding History
CAH Shares Outstanding History
CALA Shares Outstanding History
CAPR Shares Outstanding History
More Healthcare companies »

 

BMY Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.